Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine

Han-min Li

doi:10.1007/s11655-016-2460-y

Your Location：

Home >

Browse articles >

Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine

Updated：2021-08-27

- Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine
- Chinese Journal of Integrative Medicine Vol. 22, Issue 3, Pages: 163-167(2016)
- Affiliations：
  
  Institute of Liver Diseases of Hubei Provincial Hospital of Traditional Chinese Medicine, National Scientific Research Level-3 Laboratory of Cell and Molecular Biology of Traditional Chinese Medicine, Key Research Office of the State Administration of Traditional Chinese Medicine on the Treatment of Chronic Liver Diseases on the Dialectical Thought of Liver and Kidney,Wuhan,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-016-2460-y
  CLC：
- Published：2016，
  
  Published Online：27 February 2016，
Scan for full text
Li, Hm. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine., Chin. J. Integr. Med. 22, 163–167 (2016). https://doi.org/10.1007/s11655-016-2460-y

Han-min Li. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine. [J]. Chinese Journal of Integrative Medicine 22(3):163-167(2016)
Li, Hm. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine., Chin. J. Integr. Med. 22, 163–167 (2016). https://doi.org/10.1007/s11655-016-2460-y DOI：

Han-min Li. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine. [J]. Chinese Journal of Integrative Medicine 22(3):163-167(2016) DOI： 10.1007/s11655-016-2460-y.

摘要

Microcirculation of liver cancer is the micro-vascular system which comes from the tissue of liver cancer. It can offer the nutritional requirement for accelerating the cancer cell proliferation and metastasis. The intrinsic mechanism of angiogenesis is the key link in the formation of liver cancer microcirculation system. Liver regeneration microenvironment also plays an important role in the construction of liver cancer microcirculation

through the improvement of liver regeneration microenvironment affecting tumor microcirculation is the new strategy of prevention and treatment of liver cancer. In recent years

it is found that many kinds of Chinese medicine can inhibit angiogenesis

decrease the microvessel density

and delay or prevent the development of liver cancer.

Abstract

through the improvement of liver regeneration microenvironment affecting tumor microcirculation is the new strategy of prevention and treatment of liver cancer. In recent years

it is found that many kinds of Chinese medicine can inhibit angiogenesis

decrease the microvessel density

and delay or prevent the development of liver cancer.

关键词

liver microcirculationliver regeneration microenvironmentangiogenesisCurcumin

Keywords

liver microcirculationliver regeneration microenvironmentangiogenesisCurcumin

references

Xu CY, Ni QG, Zhang LY. Tumor microenvironment and tumor angiogenesis. China Healthcare Frontiers 2009;4:2123,90.

Folkmanm J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003;3:643–651.

Zhang YL, Zhou SJ, Li SW. The function of VEGF and Notch pathway in the formation of liver cancer angiogenesis. Progress Physiol Sci (Chin) 2014;45:205–208.

Li HM, Zhao BB, Gao X, Shen X, Wu Y, Zhang JR, et al. Tonifying Kidney network to modulate liver regeneration microenvironment to prevent and cure liver cancer. J Hubei Univ Tradit Chin Med (Chin) 2015;17:5–8.

Li H, Ye Q, Yin XJ, Li YM. Research progress of angiogenesis in hepatocellular carcinoma. Chin Clinic Oncol 2009;14:369–372.

Hei ZY, Wang L, Jin HM. Research progress of relationship between VEGF and angiogenesis in primary liver cancer. J Chin Microcircul (Chin) 2005;9:292–294.

Scaveni C, Vacca A, Di Pietro G, Dammacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004;18:1054–1058.

Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387–2392.

Otrock ZK, Mahfouz RA, Makarem JA, Shamseddine AI. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol Dis 2007;39:212–220.

Ding T, Xu J, Zhang Y, Guo RP, Wu WC, Zhang SD, et al. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection. Cancer 2011;117:4878–4889.

Zhong C, Wei W, Su XK, Li HD, Xu FB, Guo RP. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection. Hepatogastroenterology 2012;59:93–97.

Shi JH, Liu SZ, Wierød L, Scholz H, Anmarkrud JA, Huitfeldt HS, et al. RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver. J Surg Oncol 2013;107:393–401.

Cao GW, Wang B. Interventional nursing. Beijing: People's Medical Publishing House; 2005:7173–7174.

Li HM. Construction and application of tertiary prevention program for liver cancer based on "tonifying the Kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment". Chin J Integr Tradit West Med Liver Dis (Chin) 2015;25:369–372.

Li HM. Regulation of liver regeneration:Research progress and prospect. World Chin J Digestol 2015;23:3337–3343.

Sheng QS, Wang W. Research progress for the effect of preventing liver cancer angiogenesis by using traditional Chinese medicine. Chin J Integr Tradit West Med Liver Dis 2014;24:61–64.

Li PC, Wei AL, Zhang YQ, Tang QY. Research status on traditional Chinese medicine of angiogenesis in hepatocellular carcinoma. Popul Sci Technol (Chin) 2014;16:136–138.

Zhang B, Huang GX, Zhang YQ, Chen XX, Hu PL, Xu BP. Clinical observation on prevention of "Jia Wei Si Jun Zi Tang" from damage of hepatic reserving function after intervention of liver cancer. J Chin Med Mater 2004;27:387–389.

Cui YF, Zu MH, Xu H, Gu YM, Li GJ, Zhang QQ, et al. Severe complications after transcatheter arterial chemoembolization for hepatocellular carcinoma. Chin J Interv Imag Therapy 2005;2:31–33.

Huang G, Wang YQ, Tan MD, Xie HH, Li W, Liu GW. The research progress of curcumin antitumor mechanism. Anti- Tumor Pharm (Chin) 2014;4:328–331.

Li HM, Yan XS, Ming AP, Peng YQ. The effect of liposomecurcumin on inhibitory Bel-7402 cell proliferation and induction apoptosis. Chin J Integr Tradit West Med Liver Dis (Chin) 2005;15:214–217.

Li HM, Yan XS, Ming AP, Peng YQ, Gui WJ. Stability of anti-liver cancer efficacy by liposome-curcumin in water solution. Chin Tradit Herb Drugs (Chin) 2006;37:561–565.

Ni Q, Zeng SE, Tan N, Guo F, Zhang MY. Effect of curcumin on the proliferation and apoptosis of hepatocellular carcinoma Hepl cells. Shandong Med J (Chin) 2010;50:6–8.

Zhao BB, Li HM, Gao X, Ye ZH, Cheng SS. The herbal compound "Diwu Yanggan" modulates liver regeneration by affecting the hepatic stem cell microenvironment in 2-acetylaminofluorene/partial hepatectomy rats. Evid Based Complement Alternat Med 2015:468303.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Effects of curcumin on pain threshold and on the expression of nuclear factor κ B and CX3C receptor 1 after sciatic nerve chronic constrictive injury in rats

Inhibitory effect of cryptotanshinone on angiogenesis and Wnt/β-catenin signaling pathway in human umbilical vein endothelial cells

Electroacupuncture at Zusanli (ST36) accelerates intracerebral hemorrhage-induced angiogenesis in rats

Bone marrow angiogenesis in patients presenting with differential Chinese medicine syndrome: Correlation with the clinico-pathological features of aplastic anemia

Angiogenesis opens a way for Chinese medicine to treat stroke

Related Author

No data

Related Institution

Department of Anesthesiology, The Second Affiliated Hospital of Wenzhou Medical College

Lab, First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou

Department of Cardiology, First Affiliated Hospital of Zhejiang Chinese Medical University

Institute of Neurology, Xiangya Hospital, Central South University

Institute of Integrative Medicine, Xiangya Hospital, Central South University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰